Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Vorinostat in Combination With Niacinamide, and Etoposide for the Treatment of Patients With Relapsed and Refractory Lymphoid Malignancies

NCT00691210 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT00691210
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00691210 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Vorinostat in Combination With Niacinamide, and Etoposide for the Treatment of Patients With Relapsed and Refractory Lymphoid Malignancies
Lead sponsor
Columbia University
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2008
Completion date
March 31, 2015
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hodgkin's disease, non-hodgkin's lymphoma